What is the ticker symbol for BioVie?

BioVie trades under the ticker BIVI on NASDAQ.

What sector does BioVie operate in?

BioVie is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BIVI in a portfolio?

PortView shows BIVI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

BioVie (BIVI) Stock Analysis

NASDAQHealthcareBiotechnology

$2.06-8.04%

1-year price historyRange $0.96 – $2.28

52-week range$2.06

$0.82$3.79

What BioVie does

BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally, BioVie is advancing NE3107, which is currently undergoing a Phase III clinical trial for the management of mild to moderate Alzheimer's disease, and is also in a Phase I clinical trial for the treatment of Parkinson's disease. Further preclinical investigations are underway for NE3107, exploring its potential applications in treating multiple myeloma and prostate cancer. Established in 2013, the company adopted its current name, BioVie Inc., in July 2016, having previously operated as NanoAntibiotics, Inc. Its corporate headquarters are situated in Carson City, Nevada.

Key metrics

Market cap

$15.54M

P/E (TTM)

-0.65

EPS (TTM)

$-3.15

Beta

0.67

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.72

200-day avg

$1.49

52-week high

$3.79

52-week low

$0.82

CEO

Cuong Viet Do

ETFs linked to BIVI

Broad-market and Healthcare sector ETFs an investor holding BioVie is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how BIVI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BIVI in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for BioVie?: BioVie trades under the ticker BIVI on NASDAQ.
Which exchange is BIVI listed on?: BIVI is listed on NASDAQ.
What sector does BioVie operate in?: BioVie is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze BIVI in a portfolio?: PortView shows BIVI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.